TI
ANIP icon

Trexquant Investment’s ANI Pharmaceuticals ANIP Stock Holding History

Trexquant Investment’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.64M Buy
56,093
+1,486
+3% +$119K 0.03% 785
2026
Q1 		$4.2M Sell
54,607
-12,791
-19% -$998K 0.03% 723
2025
Q4 		$5.32M Buy
67,398
+12,513
+23% +$1.08M 0.05% 566
2025
Q3 		$5.03M Buy
54,885
+6,064
+12% +$494K 0.05% 546
2025
Q2 		$3.19M Buy
+48,821
New +$3.18M 0.04% 714
2024
Q3 		– Sell
-16,772
Closed -$1.07M – 1511
2024
Q2 		$1.07M Sell
16,772
-30,375
-64% -$1.97M 0.02% 980
2024
Q1 		$3.26M Buy
47,147
+18,663
+66% +$1.13M 0.07% 461
2023
Q4 		$1.57M Sell
28,484
-15,042
-35% -$828K 0.04% 644
2023
Q3 		$2.53M Buy
43,526
+5,607
+15% +$324K 0.06% 424
2023
Q2 		$2.04M Buy
37,919
+29,713
+362% +$1.32M 0.05% 486
2023
Q1 		$326K Buy
+8,206
New +$346K 0.01% 1170
2022
Q1 		– Sell
-10,199
Closed -$470K – 1325
2021
Q4 		$470K Buy
+10,199
New +$438K 0.03% 671
2021
Q1 		– Sell
-7,059
Closed -$205K – 1100
2020
Q4 		$205K Buy
+7,059
New +$202K 0.02% 878
2020
Q1 		– Sell
-4,213
Closed -$260K – 1078
2019
Q4 		$260K Buy
+4,213
New +$279K 0.02% 805
2018
Q2 		– Sell
-3,526
Closed -$205K – 881
2018
Q1 		$205K Buy
+3,526
New +$224K 0.01% 940
2015
Q4 		– Sell
-59,346
Closed -$2.34M – 990
2015
Q3 		$2.34M Buy
59,346
+48,946
+471% +$2.78M 0.2% 112
2015
Q2 		$645K Buy
10,400
+1,600
+18% +$95.2K 0.07% 514
2015
Q1 		$550K Buy
+8,800
New +$535K 0.06% 649

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Trexquant Investment's ANIP Position: Q2 2026 in Review

Trexquant Investment increased its ANI Pharmaceuticals (ANIP) stake by 2.7% in Q2 2026, buying an estimated $119K and bringing the position to 56,093 shares worth $4.64M. The position accounts for 0.03% of the portfolio, ranked #785.

Trexquant Investment first reported a position in ANIP in Q1 2015 and has held it in 18 quarters since. The position peaked at $5.32M in Q4 2025. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Trexquant Investment held 56,093 shares of ANI Pharmaceuticals worth $4.64M as of Q2 2026.
  • Trexquant Investment bought 1,486 ANI Pharmaceuticals shares in Q2 2026, an estimated $119K.
  • ANI Pharmaceuticals made up 0.03% of Trexquant Investment's portfolio in Q2 2026, its #785 holding.
  • Trexquant Investment first reported a position in ANI Pharmaceuticals in Q1 2015 and has held it in 18 quarters since.
  • Trexquant Investment's ANI Pharmaceuticals position peaked at $5.32M in Q4 2025.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.